Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Psychopharmacology|April 19, 2003
H3 receptor blockade by thioperamide enhances cognition in rats without inducing locomotor sensitizationVictoria A Komater, Kaitlin E Browman, Peter Curzon, et al.Pharmacology, Biochemistry, and Behavior|January 13, 2010
ABT-594 improves performance in the 5-choice serial reaction time task under conditions of increased difficulty, sub-chronic dosing, and in poorly-performing subjectsEric G Mohler, Stanley R Franklin, Lynne E Rueter, et al.Behavioural Brain Research|June 29, 2004
Enhancement of prepulse inhibition of startle in mice by the H3 receptor antagonists thioperamide and ciproxifanKaitlin E Browman, Victoria A Komater, Peter Curzon, et al.Behavioural Brain Research|April 9, 2005
Effects of histamine H3 receptor antagonists in two models of spatial learningVictoria A Komater, Michael J Buckley, Kaitlin E Browman, et al.Behavioural Brain Research|October 12, 2010
Behavioral characterization of a mutant mouse strain lacking D-amino acid oxidase activityMin Zhang, Michael E Ballard, Ana M Basso, et al.Pharmacology, Biochemistry, and Behavior|September 13, 2005
A-412997, a selective dopamine D4 agonist, improves cognitive performance in ratsKaitlin E Browman, Peter Curzon, Jia Bao Pan, et al.Psychopharmacology|November 10, 2006
The drug-induced helplessness test: an animal assay for assessing behavioral despair in response to neuroleptic treatmentMichael E Ballard, Ana M Basso, Kelly B Gallagher, et al.Journal of the Peripheral Nervous System : JPNS|September 14, 2012
PARP inhibitors attenuate chemotherapy-induced painful neuropathyJill-Desiree Brederson, Shailen K Joshi, Kaitlin E Browman, et al.Brain Research|December 1, 2009
Mice expressing the Swedish APP mutation on a 129 genetic background demonstrate consistent behavioral deficits and pathological markers of Alzheimer's diseaseNathan R Rustay, Elizabeth A Cronin, Peter Curzon, et al.Psychopharmacology|March 5, 2013
Assessment of the abuse liability of ABT-288, a novel histamine H₃ receptor antagonistThomas J Hudzik, Ana Basso, Janel M Boyce-Rustay, et al.Pageof 3